Myocilin
Myocilin Molecule Information
Name:Myocilin
Target Synonym:Trabecular meshwork-induced glucocorticoid response protein;MYOC;Myocilin 55 kDa subunit;TIGR;GLC1A
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Phase ?
Myocilin Molecule Synonym Name
MYOC,Myocilin,GLC1A,GPOA,JOAG,JOAG1,TIGR
Myocilin Molecule Background
Myocilin, trabecular meshwork inducible glucocorticoid response is also known as MYOC, GLC1A, GPOA, JOAG, JOAG1, TIGR. Myocilin / MYOC contains one olfactomedin-like domain. Myocilin is believed to have a role in cytoskeletal function. MYOC is expressed in many occular tissues, including the trabecular meshwork, and was revealed to be the trabecular meshwork glucocorticoid-inducible response protein (TIGR). The trabecular meshwork is a specialized eye tissue essential in regulating intraocular pressure, and mutations in MYOC have been identified as the cause of hereditary juvenile-onset open-angle glaucoma.
Myocilin References
Myocilin Clinical Drug Information
| Name |
Research Code |
Research Phase |
Company |
Indications |
Clinical Trials |
| ISV-205 |
ISV-205 |
Phase Ⅱ |
InSite Vision, Pharmacia & Upjohn |
Glaucoma |
Details
|
A-Z